12:00 AM
 | 
May 04, 2009
 |  BC Week In Review  |  Company News  |  Deals

Biomerica deal

Biomerica purchased the assets, technology and rights to three diagnostics for Celiac disease from an undisclosed European company for an undisclosed sum. The assets include a test marketed in...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >